Nova Patents
AT293164T

VEGF receptor chimeras for the treatment of eye disorders characterized by vascular permeability

Abstract

A phenol novolac with improved the modification of pharmacokinetics chimeric polypeptide. Specifically speaking, a phenol novolac to any pharmacokinetics wherein the prepared with the invention claims Flt1 coupling polypeptide. To a phenol novolac the preparation and use of a modifying the polypeptide, comprising, but not limit to the use of modifying the polypeptide to reduce of the apoa-i from plasma outlet of the vessel permeability of n-methyl-1-.

Term

Term ended

Expired 23 May 2020, 6.3 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

199 members in 40 offices

This recordMember, by publication datePriority claim30 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
13813399United States of AmericaP
0014142United States of AmericaW

Members199

Family members, oldest first
DocumentOfficeKind
CA2376379A1CanadaA1
CA2588221A1CanadaA1
WO0075319A1World Intellectual Property Organization (WIPO)A1
AU5040400AAustraliaA
NO20016036D0NorwayD0
NO20016036LNorwayL
NO20100656LNorwayL
EP1183353A1European Patent Office (EPO)A1
KR20020019070ARepublic of KoreaA
BR0011407ABrazilA
MXPA01012630AMexicoA
CA2436748A1CanadaA1
WO02060489A1World Intellectual Property Organization (WIPO)A1
IL146890D0IsraelD0
HU0201515A2HungaryA2
HUP0201515A2HungaryA2
CN1369009AChinaA
HK1043388A1Hong Kong, ChinaA1
CZ20014387A3CzechiaA3
ZA200110068BSouth AfricaB
JP2003501089AJapanA
US2003017977A1United States of AmericaA1
SK17522001A3SlovakiaA3
PL352246A1PolandA1
EP1363677A1European Patent Office (EPO)A1
US2004014667A1United States of AmericaA1
NZ515913ANew ZealandA
YU86901AYugoslavia, later Serbia and Montenegro (until 2006)A
MXPA03006806AMexicoA
JP2004523533AJapanA
EP1363677A4European Patent Office (EPO)A4
UY28396A1UruguayA1
US6833349B2United States of AmericaB2
HU0201515A3HungaryA3
HUP0201515A3HungaryA3
US2004266686A1United States of AmericaA1
AU2004252175A1AustraliaA1
CA2529660A1CanadaA1
WO2005000895A2World Intellectual Property Organization (WIPO)A2
AU779303B2AustraliaB2
US2005043236A1United States of AmericaA1
EP1183353B1European Patent Office (EPO)B1
AT293164TThis recordAustriaT
ATE293164T1AustriaT1
TW200513532ATaiwan Province of ChinaA
AU2005201365A1AustraliaA1
HRP20010908A2CroatiaA2
DE60019415D1GermanyD1
EP1544299A1European Patent Office (EPO)A1
PT1183353EPortugalE
US2005163798A1United States of AmericaA1
ES2237429T3SpainT3
DK1183353T3DenmarkT3
US2005175610A1United States of AmericaA1
WO2005000895A3World Intellectual Property Organization (WIPO)A3
AR044938A1ArgentinaA1
US2005245447A1United States of AmericaA1
UA74146C2UkraineC2
US2005260203A1United States of AmericaA1
RU2265661C2Russian FederationC2
US2006030529A1United States of AmericaA1
MXPA05013641AMexicoA
DE60019415T2GermanyT2
US2006058234A1United States of AmericaA1
NO20060483LNorwayL
EP1639007A2European Patent Office (EPO)A2
IL172404D0IsraelD0
HRP20010908B1CroatiaB1
HK1082511A1Hong Kong, ChinaA1
RU2006102497ARussian FederationA
US7070959B1United States of AmericaB1
US2006148705A1United States of AmericaA1
US7087411B2United States of AmericaB2
CN1816566AChinaA
BRPI0412125ABrazilA
KR20060096184ARepublic of KoreaA
KR100659477B1Republic of KoreaB1
ZA200600157BSouth AfricaB
CA2376379CCanadaC
AU2005201365B2AustraliaB2
US7279159B2United States of AmericaB2
JP2007528708AJapanA
US7303746B2United States of AmericaB2
US7303747B2United States of AmericaB2
US7306799B2United States of AmericaB2
US7374757B2United States of AmericaB2
US7374758B2United States of AmericaB2
IL146890AIsraelA
US7396664B2United States of AmericaB2
US7399612B2United States of AmericaB2
EP1947118A1European Patent Office (EPO)A1
US2008194460A1United States of AmericaA1
US2008194799A1United States of AmericaA1
US2008220004A1United States of AmericaA1
IL190234D0IsraelD0
EP1544299B1European Patent Office (EPO)B1
NZ544569ANew ZealandA
AT417928TAustriaT
ATE417928T1AustriaT1
RS50073BSerbiaB
Showing 100 of 199